Drug Shortage Report for CEFAZOLIN FOR INJECTION USP

Last updated on 2019-06-12 History
Report ID 64225
Drug Identification Number 02308932
Brand name CEFAZOLIN FOR INJECTION USP
Common or Proper name CEFAZOLIN
Company Name SANDOZ CANADA INCORPORATED
Active Ingredient(s) CEFAZOLIN
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 10PSOIJ
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2018-07-02
Estimated end date 2020-03-30
Actual end date
Shortage status Actual shortage
Updated date 2019-06-12
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2019-06-12 French Compare
v11 2019-06-12 English Compare
v10 2019-05-07 French Compare
v9 2019-05-07 English Compare
v8 2019-04-15 French Compare
v7 2019-04-15 English Compare
v6 2019-01-16 French Compare
v5 2019-01-16 English Compare
v4 2018-12-13 French Compare
v3 2018-12-13 English Compare
v2 2018-10-15 French Compare
v1 2018-10-15 English Compare